This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Ucbbiopharma Srl. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Benedicte Lallemand
Introduction
Benedicte Lallemand is a notable inventor based in Slough, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical disorders. Her work is characterized by a commitment to innovation and a focus on improving health outcomes.
Latest Patents
Benedicte Lallemand holds 1 patent for her invention titled "Dihydrocyclopenta-isoquinoline-sulfonamide derivatives compounds." This patent relates to the development of dihydrocyclopenta-isoquinoline-sulfonamide derivatives of formula (I). The invention includes processes for preparing these compounds, pharmaceutical compositions containing them, and their use in treating disorders caused by IgE. This includes allergic responses, non-allergic mast cell responses, and certain autoimmune responses, particularly those caused by the interaction of IgE with the FcεRI receptor.
Career Highlights
Benedicte Lallemand is associated with UCB Biopharma Srl, where she applies her expertise in pharmaceutical innovation. Her work has been instrumental in advancing therapeutic options for patients suffering from various conditions linked to IgE.
Collaborations
Throughout her career, Benedicte has collaborated with esteemed colleagues, including Timothy John Norman and Douglas Byrne. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Benedicte Lallemand's contributions to the field of pharmaceuticals exemplify the impact of innovation on healthcare. Her dedication to developing new compounds and therapies continues to pave the way for advancements in medical treatment.